Vivelle-dot and Sprains - a phase IV clinical study of FDA data

Summary:

Sprains is found among people who take Vivelle-dot, especially for people who are female, .

The phase IV clinical study analyzes which people take Vivelle-dot and have Sprains. It is created by eHealthMe based on reports of 2,987 people who have side effects when taking Vivelle-dot from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 03, 2022

2,987 people reported to have side effects when taking Vivelle-dot.
Among them, 7 people (0.23%) have Sprains.


What is Vivelle-dot?

Vivelle-dot has active ingredients of estradiol. It is often used in hormone replacement therapy. eHealthMe is studying from 3,256 Vivelle-dot users for its effectiveness, alternative drugs and more.

What is Sprains?

Sprains (an injury to the ligaments around a joint) is found to be associated with 951 drugs and 502 conditions by eHealthMe.

Number of Vivelle-dot and Sprains reports submitted per year:

Could Vivelle-dot cause Sprains?

Gender of people who have Sprains when taking Vivelle-dot *:

  • female: 100 %
  • male: 0.0 %

Common drugs people take besides Vivelle-dot *:

  1. Zocor: 4 people, 57.14%
  2. Nexium: 4 people, 57.14%
  3. Allegra: 4 people, 57.14%
  4. Ambien: 4 people, 57.14%
  5. Axid: 4 people, 57.14%
  6. Bentyl: 4 people, 57.14%
  7. Clarinex: 4 people, 57.14%
  8. Crestor: 4 people, 57.14%
  9. Imitrex: 4 people, 57.14%
  10. Lunesta: 4 people, 57.14%

Common side effects people have besides Sprains *:

  1. Fall: 7 people, 100.00%
  2. Weight Increased: 4 people, 57.14%
  3. Ligament Sprain (ligament stretched): 4 people, 57.14%
  4. Drug Ineffective: 4 people, 57.14%
  5. Eating Disorder: 4 people, 57.14%
  6. Emotional Distress: 4 people, 57.14%
  7. Fatigue (feeling of tiredness): 4 people, 57.14%
  8. Gastric Disorder (disease of stomach): 4 people, 57.14%
  9. Gastric Ulcer (stomach ulcer): 4 people, 57.14%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 57.14%

Common conditions people have *:

  1. Insomnia (sleeplessness): 4 people, 57.14%
  2. Stomach Discomfort (pain in abdomen): 1 person, 14.29%
  3. Muscle Spasms (muscle contraction): 1 person, 14.29%
  4. Migraine (headache): 1 person, 14.29%
  5. High Blood Cholesterol: 1 person, 14.29%
  6. Drug Hypersensitivity: 1 person, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Vivelle-dot and have Sprains?

Check whether Sprains is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Sprains and when was it recovered:

Expand to all the drugs that have ingredients of estradiol:

Alternative drugs to, pros and cons of Vivelle-dot:

Common Vivelle-dot side effects:

Browse all side effects of Vivelle-dot:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sprains treatments and more:

COVID vaccines that are related to Sprains:

Common drugs associated with Sprains:

All the drugs that are associated with Sprains:

Common conditions associated with Sprains:

All the conditions that are associated with Sprains:

How the study uses the data?

The study uses data from the FDA. It is based on estradiol (the active ingredients of Vivelle-dot) and Vivelle-dot (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: